GLOBAL MEDICAL PRODUCTS HLDGS INC
OOTC:GMDP0.00
USD
0.00
(0.00%)
ISIN
US37943L1052
CUSIP
37943L105
Return %
Stock
S&P 500
1Y
0.00
14.20
3Y
-99.00
81.12
5Y
-99.67
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Henderson United States
- Similar Companies
- Business
- Global Medical Products Holdings, Inc. is a healthcare and development-stage holding company primarily focused on identifying, evaluating, and executing strategic business combinations, mergers, and acquisitions with operating commercial enterprises across the United States and the People's Republic of China. Founded on August 27, 1997, and formerly known as 37point9, the company is headquartered in Henderson, Nevada. Historically, the company engaged in the manufacturing, sourcing, and distribution of medical supplies, laboratory consumables, and specialized pharmaceutical packaging. The company's product and service offerings encompass the development, manufacturing, and commercial distribution of EZ Trac micro-sphere diagnostic and research products for cell analysis and flow cytometry, serving academic universities, biomedical research institutions, and commercial clinical laboratories; the marketing, sourcing, and wholesale distribution of medical-grade and pharmaceutical glass packaging, including vials and containers, through its subsidiary, Global Glass Source, Ltd.; and cross-border trading, procurement, and manufacturing support services provided through its subsidiary, ECOM Shanghai International Trading. In recent operational developments and strategic shifts, Global Medical Products Holdings, Inc. transitioned from active direct manufacturing and trade operations toward functioning primarily as a corporate acquisition and development vehicle. As part of its broader restructuring and strategic realignment, the company repositioned its operations to seek reverse mergers and joint venture partnerships with established operating businesses in the healthcare, medical technology, and cross-border trade sectors, while consolidating legacy lines and maintaining an over-the-counter public listing under the ticker symbol GMDP.